|
Volumn 9, Issue 5, 2010, Pages 359-
|
RNA interference: Clinical gene-silencing success
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLODEXTRIN;
MACROGOL;
NANOPARTICLE;
RIBONUCLEOTIDE REDUCTASE;
SMALL INTERFERING RNA;
TRANSFERRIN;
TRANSFERRIN RECEPTOR;
ARTICLE;
CANCER GENE THERAPY;
CELLULAR DISTRIBUTION;
COHORT ANALYSIS;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG TARGETING;
GENE;
GENE DELIVERY SYSTEM;
GENE EXPRESSION REGULATION;
GENE SILENCING;
HUMAN;
LOW DRUG DOSE;
MELANOMA;
MOLECULARLY TARGETED THERAPY;
MULTIPLE CYCLE TREATMENT;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROTEIN TARGETING;
RNA CLEAVAGE;
RNA INTERFERENCE;
RRM2 GENE;
SOLID TUMOR;
TREATMENT RESPONSE;
TUMOR BIOPSY;
|
EID: 77951780253
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3161 Document Type: Article |
Times cited : (8)
|
References (2)
|